
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Neurofibromatosis type 1 CT scan
Introduction
Overview
Overview
There are no CT scan findings associated with neurofibromatosis type 1, however, a CT scan may be helpful in the diagnosis of complications. The use of routine screening brain CT scans in patients with neurofibromatosis type 1 is controversial.
CT scan
CT scan
- There are no CT scan findings associated with neurofibromatosis type 1.[1] However, a CT scan may be helpful in the diagnosis of complications of neurofibromatosis type 1, which include:
- Optic pathway gliomas. Early detection may prevent vision loss and improve outcomes.[2]
- Intracranial mases[3]
- Chiari malformations[3]
- Pheochromocytomas[3][4]
- Benign hamartomas[3]
- Changes in ventricular size and hydrocephalus[3]
- The use of routine screening brain CT scans in patients with neurofibromatosis type 1 is controversial. Many physicians prefer to order a CT scan at the moment of the diagnosis and repeat later only if suspicious symptoms arise[3]
References
References
- ↑ Invalid
<ref>tag; no text was provided for refs namedurlNeurofibromatosis type 1: a multidisciplinary approach to care - ScienceDirect - ↑ Listernick R, Louis DN, Packer RJ, Gutmann DH (February 1997). “Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 Optic Pathway Glioma Task Force”. Ann. Neurol. 41 (2): 143–9. doi:10.1002/ana.410410204. PMID 9029062.
- ↑ 3.0 3.1 3.2 3.3 3.4 3.5 Invalid
<ref>tag; no text was provided for refs namedurlNeurofibromatosis Type 1 Workup: Laboratory Studies, Imaging Studies, Other Tests - ↑ Karagiannis A, Mikhailidis DP, Athyros VG, Harsoulis F (December 2007). “Pheochromocytoma: an update on genetics and management”. Endocr. Relat. Cancer. 14 (4): 935–56. doi:10.1677/ERC-07-0142. PMID 18045948.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Moises Romo M.D.
